Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study compared tirzepatide and dulaglutide in improving insulin sensitivity and beta-cell function in adults with type 2 diabetes, finding tirzepatide more effective.
Tirzepatide treatment significantly improved cardiometabolic risk factors in adults with obesity or overweight.
This post-hoc analysis of the SURPASS-4 trial compared tirzepatide to insulin glargine in participants with type 2 diabetes, finding significant reductions in HbA1c and body weight with tirzepatide.
The study analyzed the efficacy of tirzepatide in patients with type 2 diabetes, showing significant reductions in HbA1c, body weight, and fasting serum glucose.
This study analyzed the sustainability of glycemic control and weight loss with tirzepatide in type 2 diabetes patients, showing significant maintenance of HbA1c and weight loss.
This study analyzed the effects of Tirzepatide on individuals with early-onset Type 2 diabetes, revealing significant improvements in various health markers.
The study investigated the effects of tirzepatide on HbA1c levels, highlighting the role of weight loss in these reductions.
This study compared tirzepatide and insulin lispro in patients with type 2 diabetes, finding significant improvements in health-related quality of life with tirzepatide.
This study investigated factors associated with body weight reduction in adults with Type 2 diabetes using tirzepatide, finding that higher doses led to greater weight loss.
This study compared the effects of Tirzepatide and Semaglutide on HbA1c and body weight in Hispanic or Latino patients with Type 2 Diabetes, finding significant reductions with Tirzepatide.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
